{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions", "item": "https://www.patentleaderboard.com/patent/6403611"}]}

Home › Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions

Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions

US Patent 6403611 · Granted Jun 11, 2002

Estimated economic value: $237,473,000 ⓘ

Assignee

Pfizer

Inventors

David B. MacLean (23 patents)
David Thompson (60 patents)

View full patent text on Google Patents →